DELAYED UPDATE — Medtronic reorgs Cardiovascular into four divisions, narrows FY EPS to $5.94–$6.00
Medtronic reorganized its Cardiovascular unit into four divisions, removed Diabetes as a reportable segment, and narrowed FY EPS guidance to $5.94–$6.00. It also raised MiniMed growth targets.
00, raising MiniMed growth targets, investing $80M in Pi—Cardia, expanding Hugo robotics and noting a put—call sell…